These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9627114

  • 1. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE.
    Oncogene; 1998 May 14; 16(19):2479-87. PubMed ID: 9627114
    [Abstract] [Full Text] [Related]

  • 2. p22/PACAP response gene 1 (PRG1): a putative target gene for the tumor suppressor p53.
    Schäfer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE.
    Ann N Y Acad Sci; 1998 Dec 11; 865():27-36. PubMed ID: 9927993
    [Abstract] [Full Text] [Related]

  • 3. The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.
    Schäfer H, Arlt A, Trauzold A, Hünermann-Jansen A, Schmidt WE.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):139-45. PubMed ID: 10448082
    [Abstract] [Full Text] [Related]

  • 4. PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line.
    Schäfer H, Trauzold A, Siegel EG, Fölsch UR, Schmidt WE.
    Cancer Res; 1996 Jun 01; 56(11):2641-8. PubMed ID: 8653710
    [Abstract] [Full Text] [Related]

  • 5. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G.
    Oncogene; 2001 Jun 14; 20(27):3573-9. PubMed ID: 11429705
    [Abstract] [Full Text] [Related]

  • 6. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N.
    Oncogene; 2001 Feb 08; 20(6):659-68. PubMed ID: 11313999
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K, Ehinger M, Svedberg H, Gullberg U.
    Cell Growth Differ; 2000 Nov 08; 11(11):561-71. PubMed ID: 11095245
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D, Wang Q, Gruber A, Björkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG, Pisa P.
    Oncogene; 2000 Oct 26; 19(45):5123-33. PubMed ID: 11064449
    [Abstract] [Full Text] [Related]

  • 9. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K.
    Cancer Res; 2003 Sep 15; 63(18):5785-92. PubMed ID: 14522900
    [Abstract] [Full Text] [Related]

  • 10. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
    Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, Swarup G.
    Oncogene; 2005 Jan 20; 24(4):627-36. PubMed ID: 15580302
    [Abstract] [Full Text] [Related]

  • 11. The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.
    Schäfer H, Diebel J, Arlt A, Trauzold A, Schmidt WE.
    FEBS Lett; 1998 Oct 02; 436(2):139-43. PubMed ID: 9781666
    [Abstract] [Full Text] [Related]

  • 12. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M, Grimaldi M, Ruaro E, Pavlenko M, Schneider C, Jenkins JR.
    Oncogene; 1996 Aug 01; 13(3):589-98. PubMed ID: 8760300
    [Abstract] [Full Text] [Related]

  • 13. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Akashi M, Osawa Y, Koeffler HP, Hachiya M.
    Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
    [Abstract] [Full Text] [Related]

  • 14. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y, Tan M, Gosink M, Wang KK, Sun Y.
    Cancer Res; 2002 May 15; 62(10):2913-22. PubMed ID: 12019172
    [Abstract] [Full Text] [Related]

  • 15. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 16. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C, Lin M, Liu J.
    Oncogene; 2004 Dec 16; 23(58):9336-47. PubMed ID: 15531928
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional activation of p53 by Pitx1.
    Liu DX, Lobie PE.
    Cell Death Differ; 2007 Nov 16; 14(11):1893-907. PubMed ID: 17762884
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY, Chan JY, Lin HC, Wang SL, Liu ST, Ho CL, Chang LC, Huang SM.
    Mol Cancer Res; 2008 Jul 16; 6(7):1204-14. PubMed ID: 18644983
    [Abstract] [Full Text] [Related]

  • 19. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, McManus BM, Yang D.
    Mol Cell Biol; 2005 Jul 16; 25(14):6247-58. PubMed ID: 15988033
    [Abstract] [Full Text] [Related]

  • 20. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N, Takada Y, Hachiya M, Ando K, Nakajima N, Akashi M.
    Cytokine; 2000 Dec 16; 12(12):1745-54. PubMed ID: 11097743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.